Jump to main content
Jump to site search

Issue 12, 2012
Previous Article Next Article

Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease

Author affiliations

Abstract

During the last decade, reports show that the incidence and prevalence of Alzheimer's disease (AD) and other dementias have significantly increased. AD poses an enormous escalating threat to health services and resources. Early diagnosis of AD is recognized as one of the major challenges and primary aims in scientific communities. With the arrival of nanoscience and nanotechnology to medicine, hopes for early diagnosis and treatment of AD have considerably increased. To this end, nanobioresearchers are focused on three major areas consisting of early detection and recognition, biological markers and diagnosis, and pharmacotherapy. Several efforts are in progress for the discovery of new nanodrugs with a sufficient effort on the fast therapy of AD. In this review, a comprehensive overview of the conventional theories together with new conflicts and challenges on the major causes of AD is provided. In addition, the opportunities and challenges of nanoscience and nanotechnology as theranostic agents for AD are discussed in detail.

Graphical abstract: Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease

Back to tab navigation
Please wait while Download options loads

Publication details

The article was received on 30 Dec 2011, accepted on 09 Mar 2012, published on 09 Mar 2012 and first published online on 09 Mar 2012


Article type: Review Article
DOI: 10.1039/C2RA01374F
Citation: RSC Adv., 2012,2, 5008-5033
  •   Request permissions

    Interdisciplinary challenges and promising theranostic effects of nanoscience in Alzheimer's disease

    S. Laurent, M. R. Ejtehadi, M. Rezaei, P. G. Kehoe and M. Mahmoudi, RSC Adv., 2012, 2, 5008
    DOI: 10.1039/C2RA01374F

Search articles by author